semaglutide membership Wegovy® – BloomMD Semaglutide: A Weight Loss Solution

Cuvillier lithographe, Briquet et fils diteurs Genve et Lemercier imprimeur Paris

Personalized plans, professional support, real changes

Have more Qs

Today our partner Amylyx Pharmaceuticals shared exciting news: the nomination of AMX0318 as a development candidate - a novel, long-acting GLP-1 receptor antagonist identified through our collaboration

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as lowering the risks of heart and kidney problems.

#addiction#treatment#AUD#FDA#University of North Carolina (UNC)Chapel Hill School of Medicine